Blog

A recent study published in Kidney International, the journal of the International Society of Nephrology, noted increasing concerns over the use of gadolinium-based contrast agents in patients with renal or liver disease.  In this article, researchers from the Oregon Health and Science University urged the use of ultrasmall superparamagnetic iron […]

A September of 2008 study published in the journal Radiology, sought to further identify those patients most at risk for the development of nephrogenic systemic fibrosis (NSF) as a result of exposure to gadolinium-based contrast agents.  Nephrogenic systemic fibrosis is an incurable, devastating disease that manifests itself as significant skin […]

A very dear friend once told me to be careful what you write in a letter, because it could come back to haunt you in the future.  That advice was given to me in the early 1980’s by the CEO of a company in my hometown of Reading, Pennsylvania.  We […]

More than six years after the Women’s Health Initiative Study was suspended due concerns regarding the long-term health risks associated with the drugs new information continues to emerge. The newest evidence, published in the Archives of Internal Medicine, was noted in the Nurses’ Health Study, a study involving 51,637 postmenopausal nurses […]

In an effort to improve our nation’s beleaguered drug safety system, the Food and Drug Administration plans to post quarterly lists of drugs that are being investigated by the Agency due to safety concerns.  The FDA cautioned that the fact that a drug is included on the list only means […]

Judge Joseph R. Goodwin, a federal judge in Charleston, West Virginia, has been selected to oversee pre-trial coordination of the Digitek litigation.  Judge Goodwin will hold the first hearing to begin the ambitious process of organizing the discovery and pre-trial procedures for all of the Digitek claims on October 10, […]